Germany
Japan
United Kingdom
China
Products
Clone OTI4C5, Anti-DDK (FLAG) monoclonal antibody, Phycoerythrin (PE)
| Applications | FC |
| Conjugation | PE |
Clone OTI4C5, Anti-DDK (FLAG) monoclonal antibody, Biotin
| Applications | FC, IF, WB |
| Conjugation | Biotin |
USD 390.00
In Stock
MHC Class I Heavy Chain (Restricted expression) mouse monoclonal antibody, clone HC10, Purified
| Applications | ELISA, EM, FC, IF, IHC, IP, WB |
| Reactivities | Human |
Fibroblasts (Pan Reticular) rat monoclonal antibody, clone ER-TR7, Purified
| Applications | FC, IF, IHC |
| Reactivities | Human, Mouse |
H2-D1 mouse monoclonal antibody, clone 28-14-8, Purified
| Applications | CT, FC, FN, IHC, IP |
| Reactivities | Mouse |
IGHG4 mouse monoclonal antibody, clone HP6025, AP, Purified
| Applications | ELISA: 1/1000-1/2000 (2-9). Immunohistochemistry on Frozen Sections: reported in literature (5,7,10,11). Immunohistochemistry on Paraffin Sections: reported in literature (10). Flow Cytometry: reported in literature (15, 18, 19). Immunocytochemistry: reported in literature (12). Western Blot: reported in literature (3,13-16). |
| Reactivities | Human |
| Conjugation | AP |
ICAM1 mouse monoclonal antibody, clone MEM-111, Purified
| Applications | ELISA, FC, IHC, WB |
| Reactivities | Bovine, Human, Rat |
USD 475.00
2 Weeks
Cd28 hamster monoclonal antibody, clone 37.51, Purified
| Applications | FC, FN, IP |
| Reactivities | Mouse |
CD1.1 mouse monoclonal antibody, clone 76-7-4, FITC
| Applications | FC |
| Reactivities | Porcine |
| Conjugation | FITC |
Anti-LGR5 mouse mAb, clone OTI2A2, DyLight 488 conjugated
| Applications | FC |
| Reactivities | Human, Mouse |
| Conjugation | DyLight 488 |
HLA Class I ABC mouse monoclonal antibody, clone W6/32, FITC
| Applications | FC |
| Reactivities | Bovine, Feline, Human, Primate |
| Conjugation | FITC |
CD8A mouse monoclonal antibody, clone MEM-31, PerCP
| Applications | FC |
| Reactivities | Human |
| Conjugation | PerCP |
HLA Class II DR mouse monoclonal antibody, clone L243, Purified
| Applications | FC, FN, IF, IHC, IP, WB |
| Reactivities | Canine, Human, Primate |
USD 220.00
2 Weeks
p75 NGF Receptor (NGFR) (1-160) mouse monoclonal antibody, clone NGFR5, Purified
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Feline, Ferret, Human, Monkey, Rabbit |
p21 (CDKN1A) mouse monoclonal antibody, clone WA-1, Purified
| Applications | FC, IF, IHC |
| Reactivities | Chimpanzee, Human, Monkey, Mouse, Rat |
CD4 mouse monoclonal antibody, clone MEM-115, Azide Free
| Applications | FC, FN, IP, WB |
| Reactivities | Human |
HA mouse monoclonal antibody, clone CB051, Biotinylated
| Applications | FC, IF, WB |
| Conjugation | Biotin |
Cd80 hamster monoclonal antibody, clone 16-10A1, Aff - Purified
| Applications | FC, FN, IHC, IP |
| Reactivities | Canine, Mouse |
USD 390.00
2 Weeks
MHC Class I Heavy Chain (Restricted expression) mouse monoclonal antibody, clone HCA2, Purified
| Applications | ELISA, FC, IF, IHC, IP, WB |
| Reactivities | Human |
p21 (CDKN1A) mouse monoclonal antibody, clone WA-1, Purified
| Applications | FC, IF, IHC |
| Reactivities | Chimpanzee, Human, Monkey, Mouse, Rat |
Mouse monoclonal anti-His Antibody, Clone OTI2B5, Phycoerythrin (PE)
| Applications | FC |
| Conjugation | PE |
EPCAM mouse monoclonal antibody, clone 323/A3, Aff - Purified
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human |
CD3E mouse monoclonal antibody, clone MEM-92, Purified
| Applications | FC, FN, IP |
| Reactivities | Human |
CD82 mouse monoclonal antibody, clone C33, Aff - Purified
| Applications | FC, FN, IF, IHC, IP, WB |
| Reactivities | Human |
Active filters
Applications
- FC
Clonalities
- Monoclonal
Filter by
Target Symbol
- PDCD1 (209)
- CD5 (194)
- HAVCR2 (123)
- CTAG1B (116)
- ERCC1 (115)
- LIPG (105)
- PECAM1 (98)
- CD274 (94)
- L1CAM (87)
- CD47 (85)
- CTNNB1 (82)
- ERBB2 (81)
- PTPRC (81)
- TP53 (81)
- PDCD1LG2 (80)
- CTLA4 (79)
- TNFRSF8 (79)
- CD8A (77)
- CD99 (75)
- CD33 (72)
- CD40 (71)
- TIGIT (70)
- ICOS (68)
- FGF21 (65)
- LRATD2 (65)
- PNMT (65)
- SENP2 (65)
- CD86 (63)
- LGR5 (61)
- CD80 (59)
- LAG3 (59)
- TNFRSF9 (59)
- AFP (57)
- ACAT2 (55)
- CD63 (55)
- MICAL1 (55)
- RNF144B (55)
- TTC32 (55)
- TTLL12 (55)
- UBE2E3 (55)
- ZFP36 (55)
- CD2 (54)
- SQSTM1 (54)
- BTLA (52)
- CDK2 (50)
- HIBCH (50)
- IGF2BP2 (50)
- KATNB1 (50)
- LENG1 (50)
- MAPK7 (50)
- MAPRE2 (50)
- MEIS3 (50)
- MOB3B (50)
- NME4 (50)
- NPR3 (50)
- PACSIN3 (50)
- PDE4A (50)
- PFKP (50)
- PRKCE (50)
- RPN1 (50)
- SDR9C7 (50)
- SMS (50)
- TACC3 (50)
- BTK (49)
- CD27 (47)
- CD19 (46)
- IL2RA (46)
- SNX9 (46)
- ACY1 (45)
- AK5 (45)
- ARHGAP25 (45)
- BECN1 (45)
- BTN1A1 (45)
- CBWD1 (45)
- CD38 (45)
- CD4 (45)
- DSTN (45)
- EPM2AIP1 (45)
- EXD1 (45)
- GSTT2 (45)
- HOXC11 (45)
- LDLRAP1 (45)
- LIMK1 (45)
- LRRC25 (45)
- NRBP1 (45)
- NT5DC1 (45)
- PDE2A (45)
- PIK3AP1 (45)
- SIRT5 (45)
- SNAP25 (45)
- SRR (45)
- STAT5A (45)
- TAL1 (45)
- TUBAL3 (45)
- CD3E (42)
- NGFR (41)
- ACY3 (40)
- AK4 (40)
- ARFGAP1 (40)
- ATP5F1B (40)
Reactivities
- Human (17204)
- Mouse (9734)
- Rat (9080)
- Monkey (2111)
- Dog (1640)
- Canine (41)
- Porcine (24)
- Primate (20)
- Escherichia coli (17)
- Rabbit (17)
- Sheep (17)
- Chimpanzee (11)
- Bovine (7)
- Goat (6)
- Baboon (5)
- Pig (5)
- SARS-CoV-2 (5)
- Cynomolgus (4)
- Chicken (3)
- Cow (3)
- Feline (3)
- Hamster (3)
- Rhesus Monkey (3)
- Dengue virus (2)
- Drosophila (2)
- Ferret (2)
- Macaque (2)
- Marmoset (2)
- West Nile Virus (2)
- Yellow Fever Virus (2)
- C. elegans (1)
- Equine (1)
- Fish (1)
- Guinea Pig (1)
- Squirrel (1)
- Xenopus (1)
- Yeast (1)
Antibody Hosts
Isotypes
- IgG1 (14164)
- IgG2a (4404)
- IgG2b (3217)
- IgG, kappa (231)
- IgG (211)
- IgM (210)
- IgG1, kappa (196)
- IgG3 (123)
- IgG2a, kappa (82)
- IgG2b, kappa (39)
- IgG2c (23)
- IgG1, lambda (22)
- IgA (16)
- IgG2 (8)
- Fab fragment, kappa (7)
- IgG2a, lambda (6)
- IgM, kappa (5)
- IgG4 (4)
- IgG3, kappa (3)
- Fab fragment, lambda (2)
- IgG1/IgG2a (2)
- IgG2b, lambda (2)
- scFv (2)
- cocktail (1)
Conjugates
- Unconjugated (10944)
- Biotin (3727)
- HRP (3259)
- FITC (937)
- PE (797)
- APC (174)
- Alexa Fluor 488 (55)
- Alexa Fluor 647 (51)
- PerCP (38)
- PE-Cy7 (22)
- Cy5 (18)
- Alexa Fluor 546 (17)
- APC-Cy7 (14)
- APC-Cy5.5 (10)
- His Tag (9)
- DyLight 488 (7)
- PE-TXRD (7)
- PE-Cy5.5 (6)
- PE-DL594 (4)
- BIMA (3)
- FLMA (3)
- PerCP-Cy5.5 (3)
- AP (1)
- DyLight 594 (1)
- DyLight 633 (1)
- PE-Cy5 (1)
Knockout (KO) Validation
Modifications
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (55)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2a format, for improved compatibility with existing reagents, assays and techniques. (34)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (18)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (17)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (16)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques. (16)
- This is a chimeric antibody created as part of a panel offering antibodies of the same specificity in different formats (species, isotype, subtype and modified versions) for use as isotype controls. (14)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (13)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (12)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (10)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques. (9)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (7)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human Fab format, for improved compatibility with existing reagents, assays and techniques. (7)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2a format, for improved compatibility with existing reagents, assays and techniques. (6)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (4)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgM format, for improved compatibility with existing reagents, assays and techniques. (4)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG2 format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original rat IgG2a format, for improved compatibility with existing reagents, assays and techniques. (3)
- This full-length, chimeric rabbit antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques. (3)
- Phospho-specific (2)
- This chimeric hamster (Armenian) antibody was made using the variable domain sequences of the original Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG3 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2b format, for improved compatibility with existing reagents, assays and techniques. (2)
- This full-length, reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques. (2)
- This reformatted rat antibody was made using the variable domain sequences of the original Rat IgG format, for improved compatibility with existing reagents, assays and techniques. (2)
- This reformatted rat antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This reformatted human antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric human antibody was made using the variable domain sequences of the original IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric human antibody was made using the variable domain sequences of the original Mouse IgM format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric murine antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Armenian Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Armenian Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgM format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This is a chimeric antibody created to reduce immunogenicity during in vivo applications. (1)
- This is a chimeric mouse antibody, based on the original hamster IgG format, created for improved compatibility with existing reagents, assays and techniques. (1)
- This is a chimeric mouse antibody, based on the original rat IgG2b format, created for improved compatibility with existing reagents, assays and techniques. (1)
- This is a chimeric recombinant Fab fragment created as part of a panel offering antibodies of the same specificity in different formats (species, isotype, subtype and modified versions) for use as isotype controls. (1)
- This is a reformatted human IgG1 antibody based on the therapeutic Fab fragment. NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (1)
- This reformatted antibody was made using the variable domain sequences of the original rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original mouse scFv format for improved compatibility with existing reagents, assays and techniques. (1)
Assay Types
Families
- Druggable Genome (10460)
- Transmembrane (4771)
- Transcription Factors (1581)
- ES Cell Differentiation/IPS (1528)
- Secreted Protein (1213)
- Protease (912)
- Protein Kinase (864)
- Stem cell - Pluripotency (635)
- Adult stem cells (363)
- Phosphatase (313)
- Embryonic stem cells (181)
- P450 (155)
- Ion Channels: Other (117)
- Stem cell relevant signaling - DSL/Notch pathway (105)
- Stem cell relevant signaling - JAK/STAT signaling pathway (99)
- GPCR (97)
- Cancer stem cells (94)
- Induced pluripotent stem cells (64)
- Nuclear Hormone Receptor (39)
- Ion Channels: Potassium (30)
- Stem cell relevant signaling - TGFb/BMP signaling pathway (21)
- Stem cell relevant signaling - Wnt Signaling pathway (11)
Pathways
- Metabolic pathways (2200)
- Cell adhesion molecules (CAMs) (1332)
- Pathways in cancer (866)
- Hematopoietic cell lineage (800)
- T cell receptor signaling pathway (692)
- Cytokine-cytokine receptor interaction (614)
- MAPK signaling pathway (579)
- Prostate cancer (448)
- Purine metabolism (445)
- Leukocyte transendothelial migration (419)
- Focal adhesion (414)
- Primary immunodeficiency (413)
- Progesterone-mediated oocyte maturation (392)
- Regulation of actin cytoskeleton (376)
- Cell cycle (363)
- Toll-like receptor signaling pathway (363)
- Neurotrophin signaling pathway (358)
- Endometrial cancer (356)
- Colorectal cancer (341)
- Chronic myeloid leukemia (333)
- Jak-STAT signaling pathway (327)
- Pancreatic cancer (327)
- Fc gamma R-mediated phagocytosis (326)
- Systemic lupus erythematosus (325)
- Huntington's disease (320)
- Apoptosis (318)
- Non-small cell lung cancer (315)
- Melanoma (309)
- Insulin signaling pathway (308)
- Adherens junction (303)
- Endocytosis (297)
- ErbB signaling pathway (297)
- Alzheimer's disease (292)
- Autoimmune thyroid disease (283)
- Bladder cancer (280)
- Wnt signaling pathway (280)
- Glycolysis / Gluconeogenesis (275)
- B cell receptor signaling pathway (271)
- Pathogenic Escherichia coli infection (265)
- Small cell lung cancer (261)
- Ubiquitin mediated proteolysis (260)
- Tight junction (246)
- Glioma (242)
- Allograft rejection (236)
- Pyruvate metabolism (231)
- Viral myocarditis (231)
- Nucleotide excision repair (218)
- p53 signaling pathway (217)
- Arginine and proline metabolism (216)
- Thyroid cancer (216)
- Axon guidance (215)
- Fc epsilon RI signaling pathway (214)
- Glycerolipid metabolism (211)
- Natural killer cell mediated cytotoxicity (209)
- Gap junction (204)
- Acute myeloid leukemia (202)
- Valine (191)
- Parkinson's disease (187)
- Adipocytokine signaling pathway (186)
- Oxidative phosphorylation (186)
- Drug metabolism - cytochrome P450 (185)
- leucine and isoleucine degradation (181)
- Fructose and mannose metabolism (179)
- Oocyte meiosis (177)
- Graft-versus-host disease (173)
- Metabolism of xenobiotics by cytochrome P450 (172)
- ECM-receptor interaction (170)
- Type I diabetes mellitus (170)
- Basal cell carcinoma (166)
- Type II diabetes mellitus (166)
- Tyrosine metabolism (160)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (157)
- Proteasome (153)
- Calcium signaling pathway (151)
- Pyrimidine metabolism (151)
- Antigen processing and presentation (149)
- Renal cell carcinoma (149)
- Glycine (147)
- serine and threonine metabolism (147)
- Amyotrophic lateral sclerosis (ALS) (139)
- Chemokine signaling pathway (139)
- Glutathione metabolism (138)
- GnRH signaling pathway (138)
- Propanoate metabolism (126)
- mTOR signaling pathway (125)
- TGF-beta signaling pathway (121)
- Tryptophan metabolism (121)
- Retinol metabolism (120)
- Complement and coagulation cascades (118)
- Cysteine and methionine metabolism (111)
- Histidine metabolism (111)
- beta-Alanine metabolism (111)
- Melanogenesis (109)
- Fatty acid metabolism (106)
- VEGF signaling pathway (105)
- Lysosome (103)
- Pentose phosphate pathway (103)
- Arachidonic acid metabolism (102)
- Vascular smooth muscle contraction (98)
- Butanoate metabolism (96)
- Renin-angiotensin system (94)
- Regulation of autophagy (91)
- Asthma (90)
- Epithelial cell signaling in Helicobacter pylori infection (89)
- Nicotinate and nicotinamide metabolism (87)
- Citrate cycle (TCA cycle) (83)
- Terpenoid backbone biosynthesis (82)
- Lysine degradation (81)
- Hypertrophic cardiomyopathy (HCM) (78)
- NOD-like receptor signaling pathway (76)
- Glyoxylate and dicarboxylate metabolism (75)
- Dilated cardiomyopathy (74)
- Amino sugar and nucleotide sugar metabolism (72)
- PPAR signaling pathway (72)
- Starch and sucrose metabolism (72)
- Linoleic acid metabolism (70)
- Synthesis and degradation of ketone bodies (70)
- Neuroactive ligand-receptor interaction (68)
- Porphyrin and chlorophyll metabolism (65)
- RIG-I-like receptor signaling pathway (64)
- Alanine (62)
- Galactose metabolism (62)
- aspartate and glutamate metabolism (62)
- DNA replication (61)
- Mismatch repair (61)
- Vibrio cholerae infection (58)
- N-Glycan biosynthesis (57)
- Long-term depression (56)
- Caffeine metabolism (55)
- Cardiac muscle contraction (55)
- Notch signaling pathway (54)
- Prion diseases (54)
- Cytosolic DNA-sensing pathway (53)
- Inositol phosphate metabolism (50)
- RNA degradation (50)
- Ascorbate and aldarate metabolism (46)
- Maturity onset diabetes of the young (46)
- Androgen and estrogen metabolism (45)
- One carbon pool by folate (45)
- SNARE interactions in vesicular transport (45)
- Long-term potentiation (41)
- Drug metabolism - other enzymes (40)
- Non-homologous end-joining (40)
- Spliceosome (36)
- Cyanoamino acid metabolism (35)
- Folate biosynthesis (35)
- Homologous recombination (35)
- Selenoamino acid metabolism (35)
- Sulfur metabolism (35)
- Pantothenate and CoA biosynthesis (32)
- Phosphatidylinositol signaling system (31)
- Base excision repair (29)
- Phenylalanine metabolism (22)
- Aminoacyl-tRNA biosynthesis (20)
- Basal transcription factors (20)
- Glycosaminoglycan degradation (20)
- RNA polymerase (20)
- Vitamin B6 metabolism (20)
- ABC transporters (18)
- Nitrogen metabolism (18)
- Riboflavin metabolism (18)
- Biosynthesis of unsaturated fatty acids (17)
- Methane metabolism (17)
- Circadian rhythm - mammal (15)
- Dorso-ventral axis formation (15)
- Glycerophospholipid metabolism (15)
- Thiamine metabolism (15)
- Hedgehog signaling pathway (13)
- Limonene and pinene degradation (11)
- Other glycan degradation (10)
- Pentose and glucuronate interconversions (10)
- Sphingolipid metabolism (10)
- leucine and isoleucine biosynthesis (10)
- Glycosphingolipid biosynthesis - lacto and neolacto series (6)
- Olfactory transduction (6)
- Biotin metabolism (5)
- C21-Steroid hormone metabolism (5)
- Glycosphingolipid biosynthesis - ganglio series (5)
- Keratan sulfate biosynthesis (5)
- Steroid biosynthesis (5)